influenc
differ
antiproteinas
agent
alphaviru
replic
examin
sindbi
viru
multicycl
replic
cultur
cell
suppress
notosylphenylalanin
chloromethyl
keton
tpck
inhibitor
chymotrypsinlik
proteinas
aprotinin
inhibitor
wide
spectrum
proteinas
antivir
activ
tpck
also
demonstr
sindbi
virusinfect
anim
parenter
inject
tpck
infect
mice
reduc
viru
titer
brain
blood
possibl
mechan
antivir
action
antiproteinas
agent
discuss
well
known
virusspecif
protein
mani
virus
includ
alphavirus
proteolyt
cleav
viru
replic
proteolyt
process
necessari
develop
infect
base
observ
suggest
inhibit
proteolysi
viral
protein
would
result
inhibit
viru
replic
antiproteinas
agent
could
use
purpos
review
see
explor
chemotherapeut
approach
abl
suppress
influenza
paramyxoviru
infect
blockag
viru
glycoprotein
cleavag
antiproteinas
benefici
result
obtain
clinic
trial
antiproteinas
aerosol
inhal
influenza
outbreak
commun
present
experiment
data
propos
chemotherapeut
approach
alphaviru
infect
studi
abil
differ
proteinas
inhibitor
suppress
sindbi
viru
alphaviru
multicycl
replic
cultur
cell
infect
anim
follow
proteinas
inhibitor
chosen
examin
antivir
effect
ntosylphenylalanin
chloromethyl
keton
tpck
inhibitor
chymotrypsinlik
proteinas
n
ctosylllysin
chloromethyl
keton
tlck
inhibitor
trypsinlik
proteinas
aprotinin
inhibitor
wide
spectrum
proteinas
trypsin
chymotrypsin
cathepsin
plasmin
etc
two
aprotinin
compound
kallikreintrypsin
inhibitor
lyophil
form
produc
gedeon
richter
hungari
design
aprotin
produc
veb
arzneimittelwerk
gdr
term
aprotininc
use
respect
antiproteinas
specif
compound
analog
produc
bayer
ag
aprotinin
disulfidelink
polypeptid
dimer
molecular
weight
obtain
anim
organ
wide
use
medic
practic
prevent
hyperfibrinolysi
treat
pancreat
sindbi
viru
propag
brain
suckl
mice
appropri
dilut
brain
suspens
use
infect
cultur
cell
experiment
mice
twodayold
primari
cultur
chicken
embryo
cell
cec
infect
viru
multipl
plaqu
form
unit
pfu
per
cell
rain
viru
inoculum
remov
cell
incub
medium
supplement
mm
hepe
ph
antiproteinas
agent
experi
mm
tpck
dmso
use
stock
solut
dilut
warm
medium
ad
cell
monolay
tlck
prepar
aqueou
solut
alkalin
medium
ph
use
permit
stabl
replic
ofalphavirus
cultur
cec
neutral
ph
medium
zhirnov
et
al
unpublish
data
h
incub
cultur
medium
remov
assay
infect
cell
wash
medium
lack
antiproteinas
studi
cellular
polypeptid
synthesi
cell
monolay
incub
addit
min
algal
hydrolys
dissolv
hank
salt
solut
without
proteinas
inhibitor
previous
describ
cellular
polypeptid
dissolv
sd
dithiothreitol
ph
equal
aliquot
put
electrophoret
gel
mice
g
infect
intramuscularli
sindbi
viru
multipl
pfumous
infect
either
physiolog
salin
placebo
commerci
solut
kallikrein
inhibitor
unit
kiu
mous
tpck
ml
lal
solutionmous
inject
intraperiton
inject
repeat
h
interv
day
differ
time
infect
anim
anim
day
group
kill
homogen
brain
blood
prepar
tissu
homogen
assay
infect
plaqu
method
cultur
cec
cec
grown
flask
infect
mlflask
viru
dilut
medium
min
adsorpt
inoculum
remov
cell
overlaid
ml
bactoagar
difco
prepar
medium
supplement
ggml
deaedextran
mm
hepe
ph
plaqu
count
h
postinfect
neutral
red
stain
cellular
polypeptid
submit
electrophoresi
gradient
polyacrylamid
gel
use
trisglycinesd
buffer
follow
gel
autoradiographi
describ
molecular
weight
viral
polypeptid
evalu
accord
weber
osborn
influenza
viru
protein
marker
abil
differ
proteinas
inhibitor
suppress
multicycl
sindbi
viru
replic
cultur
cell
studi
preliminari
experi
purpos
cell
monolay
primarili
infect
low
viru
dose
incub
antiproteinasecontain
medium
incub
medium
remov
infect
cell
process
analysi
protein
synthesi
three
pattern
polypeptid
synthesi
could
expect
experi
first
viru
replic
might
fail
suppress
proteinas
inhibitor
monolay
therefor
would
total
infect
due
effect
multicycl
viru
replic
synthesi
viru
protein
would
reveal
second
antiproteinas
agent
may
suffer
viru
replic
without
concomit
toxic
host
cell
host
cell
protein
synthesi
would
detect
sampl
third
cell
monolay
might
damag
toxic
concentr
proteinas
inhibitor
case
p
otein
synthesi
would
markedli
reduc
even
abolish
result
typic
experi
repres
fig
line
fig
show
viru
protein
synthesi
cours
infect
host
protein
synthesi
virtual
shut
synthesi
viru
nonstructur
b
w
kda
nsp
kda
kda
structur
kda
kda
kda
c
kda
polypeptid
domin
cell
cultur
h
postinfect
fig
line
result
indic
multicycl
replic
sindbi
viru
cec
lead
total
infect
monolay
also
seen
tlck
aprotininc
induc
visibl
antivir
activ
synthesi
main
viru
protein
clearli
detect
cell
monolay
incub
high
concentr
inhibitor
fig
line
contrast
aprotin
concentr
kiuml
higher
demonstr
mark
reduct
cf
irusspecif
protein
synthesi
fig
line
aprotin
toxic
cell
suppress
host
protein
synthesi
concentr
kiuml
data
shown
detail
experi
design
studi
antivir
activ
tpck
report
alkyl
activ
thu
could
toxic
cell
result
experi
demonstr
fig
c
seen
tpck
concentr
p
caus
antivir
activ
concentr
gm
tpck
markedli
reduc
viru
polypeptid
synthesi
without
affect
host
cell
synthesi
initi
toxic
result
decreas
protein
synthesi
observ
p
tpck
extens
cell
damag
seen
concentr
lam
fig
line
fig
ic
line
also
seen
sampl
synthesi
viru
polypeptid
reduc
synthesi
kda
kda
host
polypeptid
enhanc
fig
line
similar
parallel
denot
cell
treat
high
concentr
aprotin
fig
line
tabl
cell
process
examin
polypeptid
synthesi
cellular
polypeptid
synthes
analyz
electrophoresi
gradient
polyacrylamid
gel
fig
ia
line
data
inhibit
viru
protein
synthesi
tpck
aprotin
fulli
correl
result
indic
decreas
viru
yield
cultur
fluid
antiproteinasetr
cell
see
tabl
infect
data
confirm
sindbi
viru
replic
effect
placebotr
mice
almost
complet
inhibit
viru
replic
brain
decreas
viru
blood
major
tpcktreat
mice
observ
third
day
infect
mean
viru
titer
log
pfuml
blood
placebo
aprotinin
g
tpcktreat
mice
respect
statist
signific
viru
titer
reduct
blood
tpckotreat
mice
p
mean
viru
titer
brain
control
tpcktreat
mice
day
infect
respect
mean
valu
three
independ
experi
decreas
statist
signific
p
clear
antivir
effect
observ
tpck
dose
lagmous
per
day
fig
wherea
less
promin
effect
seen
tpck
lagmous
per
day
data
shown
primari
nonleth
toxic
symptom
hypothermia
reduc
weight
gain
etc
found
occur
tpck
dose
lagmous
per
day
data
shown
aprotin
caus
reduct
overal
viru
yield
mous
brain
howev
aprotin
delay
viru
replic
brain
brought
slight
reduct
viraemia
see
fig
data
present
show
alphaviru
multicycl
multipl
cultur
cell
suppress
antiproteinas
agent
concentr
caus
toxic
host
cell
onecycl
growth
alphaviru
cell
cultur
report
previous
inhibit
high
concentr
lam
tpck
concentr
agreement
data
found
toxic
cec
within
h
incub
concentr
inhibitor
induc
reduct
cellular
protein
synthesi
therefor
viru
inhibit
achiev
high
tpck
concentr
may
result
toxic
host
cell
exact
mechan
antivir
activ
antiproteinas
agent
clear
await
studi
inhibit
viru
replic
tpck
like
due
inhibit
proteinas
respons
viru
protein
cleavag
high
concentr
lam
tpck
report
suppress
proteolysi
structur
polypeptid
sindbi
virusinfect
cell
block
proteolyt
process
kda
polyprotein
precursor
nonstructur
polymeraseassoci
nsp
protein
sindsbi
viru
partial
inhibit
proteolyt
format
viral
protein
c
appear
high
molecular
weight
precursor
note
cell
infect
anoth
alphaviru
semliki
forest
viru
expos
high
concentr
lam
tpck
examin
antiproteolyt
activ
tpck
alphavirusinfect
cell
see
reduct
c
e
proteolyt
format
partial
inhibit
cleavag
obtain
nontox
concentr
lam
tpck
zhirnov
et
al
unpublish
result
hand
tpck
report
interact
select
structur
protein
p
measl
viru
similar
direct
interact
tpck
alphavirusspecif
protein
may
affect
intracellular
convers
antivir
activ
aprotinin
probabl
due
antiproteinas
action
drug
aprotin
shown
penetr
influenzainfect
cell
inhibit
intracellular
proteolysi
viral
nucleocapsid
protein
anoth
preced
blockag
intracellular
proteolyt
process
viru
protein
exogenu
antiproteinas
cystatin
molecular
weight
proteinas
inhibitor
prepar
chicken
egg
ad
polioviru
infect
cell
report
alter
proteolysi
viru
polyprotein
reduc
viru
yield
although
virusspecif
proteolysi
seem
plausibl
target
antiproteinas
agent
explan
antivir
activ
ofantiproteinas
agent
exclud
instanc
antiproteinas
agent
may
directli
block
fusion
andor
deprotein
virion
intern
host
cell
inde
earli
stage
retroviru
coronavirushost
cell
interact
inhibit
leupeptin
tripeptid
proteinas
inhibitor
hand
antiproteinas
tpck
tlck
pmsf
aprotinin
fail
block
penetr
measl
viru
coronaviru
cell
antivir
activ
antiproteinas
may
mediat
host
cell
alphaviru
replic
well
known
interrel
host
cell
metabol
imbal
host
cell
metabol
factor
could
provok
antiproteinas
agent
may
lead
inhibit
viru
develop
aprotininand
tpcktreat
cell
tempt
specul
superproduct
kda
kda
host
protein
effector
determin
inabl
cell
maintain
viru
replic
similar
resist
interferontr
mous
cell
influenza
viru
shown
mediat
molecular
weight
host
protein
mx
intracellular
product
appear
enhanc
interferon
report
tpck
aprotinin
inhibit
multipl
alphaviru
cultur
cell
tpck
found
suppress
viru
replic
infect
anim
result
explain
differenti
transport
antiproteinas
agent
toward
viral
target
anim
tpck
low
molecular
weight
phenylalanin
analogu
well
known
penetr
effect
cell
membran
thu
tpck
distribut
host
organ
possibl
adequ
antivir
target
aprotinin
molecular
weight
polypeptid
distribut
organ
therefor
could
insuffici
inhibit
alphaviru
replic
antivir
activ
tpck
anim
shown
mainli
theoret
signific
much
need
known
toxic
exact
mode
action
antiproteinas
agent
whole
organ
elucid
factor
may
allow
design
effect
nontox
antivir
appropri
deliveri
viral
target
